口服药控制不理想的2型糖尿病联用甘精胰岛素治疗的疗效观察被引量：6

下载PDF

导出

摘要目的探讨对于口服降糖药不能很好控制血糖的2型糖尿病患者联合甘精胰岛素治疗的临床疗效。方法选择口服降糖药血糖控制不理想的2型糖尿病患者30例,睡前加用甘精胰岛素治疗,观察治疗前后空腹血糖(FBG)、餐后2 h血糖(2hPG)、糖化血红蛋白(HbA1c)、体质量指数(BMI)等变化和低血糖发生率。结果联合甘精胰岛素治疗4周后,FBG、2hPG均较治疗前明显下降(P均<0.05),治疗12周后HbA1c较治疗前也显著下降(P<0.05),而BMI治疗前后无显著性差异。结论 2型糖尿病患者口服降糖药血糖控制不理想时,睡前联合注射甘精胰岛素安全有效,患者依从性好且低血糖发生率低。

作者赖淑琴

机构地区山西省孝义市人民医院

出处《现代中西医结合杂志》 CAS 2013年第13期1406-1407,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine

关键词 2型糖尿病甘精胰岛素口服降糖药

分类号 R587.1 [医药卫生—内分泌]

引文网络
相关文献

参考文献10

1Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with microvascular and microvascular complications of type 2 diabe- tes: prospective observational study ( UKPDS 35 ) [ J ]. BMJ,2000, 321(12) :405 -412.
2Klein R, Klein BE, Moss SE. Relation of glycemic control to diabet- ic microvascular complications indiabetes mellitus [ J ]. Ann Intern Med, 1996,124 ( 1 Pt 2) :90 - 96.
3潘长玉,田慧,刘国良,李秀钧,傅祖植,陈家伟,暨亚洲糖尿病管理中国协作组.中国城市中心医院糖尿病健康管理调查[J].中华内分泌代谢杂志,2004,20(5):420-424. 被引量：193
4卜石,邢小燕,王娜,赵文惠,杨文英.长效胰岛素联合口服降糖药治疗2型糖尿病的疗效与安全性[J].中国循证医学杂志,2004,4(7):464-467. 被引量：157
5Cryer PE. The barrier of hypoglycemia in diabetes[ J]. Diabetes, 2008,57:3169 - 3176.
6Cryer PE. Elimination of hypoglycemia from the lives of people af- fected by diabetes [ J ]. Diabetes, 2011,60:24 - 27.
7Rosenstock J,Dailey G,Massi-Bcncdetti M,et al. Reduced hypogly- cemia risk with insulin glargine:a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes[ J]. Diabetes Care, 2005,28 : 950 - 955.
8Levien TL,Baker DE, Whit e JR Jr, et al. Insulin glargine:a new basal insulin [ J ]. Ann Pharmacother, 200,2,36 ( 6 ) : 1019 - 1027.
9Riddle MC, Rosenstock J, Gerich 3, et al. The treat-to-target triM: randomized addition of glargine or human NPH insulin to oral thera- py of type 2 diabetic patients [ J ]. Diabetes Care, 2003,26 ( 11 ) : 3080 -3086.
10Halter JB,Kennedy L,Herman WH. Glycemic control and safety of insulin glargine in elderly patients with type 2 diabetes mellitus:the Goal A 1 c Study [ J ]. Diabetes,2006,55 ( Supple 1 ) : A114.

二级参考文献12

1陆小平,王闻博,晏玲,龚雄辉,崔岚,刘悦,张小苏,李秀梅,王鸿玉.吸烟对男性2型糖尿病患者血糖控制的影响[J].中华内分泌代谢杂志,2003,19(4):294-295. 被引量：28
2张家庆.血糖及其他体液葡萄糖测定进展[J].中华内分泌代谢杂志,2003,19(4):333-335. 被引量：59
3Riddle MC,Rosenstock J,Gerich J.Insulin Glargine 4002 Study Investigators.The treat-to-target trial:randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients[J].Diabetes Care,2003; 26(11):3 080-3 086.
4HOE 901/3002 Study Group.Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes[J].Diabetes Care,2000; 23(8):1 130-1 136
5UKPDS Study Group.Stratton IM,Adler AI,Neil HAW,Matthews DR,Manley SE,Cull CA,Hadden D,Turner RC,Holman RR.Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes:prospective observational study (UKPDS 35) [J].BMJ,20
6Wright A,Burden ACF,Paisey RB.Sulfonylurea Inadequacy:Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57)[J].Diabetes Care,2002; 25(2):330-336
7Turner RC,Cull CA,Frighi V,Holman RR.Glycemic control with diet,sulfonylurea,metformin,or insulin in patients with type 2 diabetes mellitus:progressive requirement for multiple therapies (UKPDS 49).UK Prospective Diabetes Study (UKPDS) Group[J].JAMA,1999;
8UKPDS Study Group.Klein R,Klein BE,Moss SE.Relation of glycemic control to diabetic microvascular complications indiabetes mellitus[J].Ann Intern Med,1996;124(1 Pt 2):90-96
9UKPDS Study Group.Overview of six years' therapy of type 2 diabetes-a progressive disease (UKPDS 16)[J].Diabetes Care,1995; 44(11):1 249-1 258
10Matthaei S.Endocrine review[M],21(6):585-618